Aug-04-23 08:29AM. Ardelyx, Inc. (NASDAQ:ARDX) Q2 2023 Earnings Call Transcript. (Insider Monkey) Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of …Joby Aviation (NYSE: JOBY) stock is up about 8% and trending on social media and financial news websites today.The catalyst for the gains and the attention was the firm's announcement that it ...Stock Ideas. Long Ideas. Healthcare. Ardelyx: Final Countdown Begins. May 18, 2023 9:17 AM ET Ardelyx, Inc. (ARDX) Stock 63 Comments. 14 Likes. Clinically …View today's Ardelyx Inc stock price and latest ARDX news and analysis. Create real-time notifications to follow any changes in the live stock price.Jan 8, 2024 · About Ardelyx, Inc. Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs.You may remember from math class that a prime number is a number that can only be divided by 1 and itself. But why are they important anyway? Advertisement If you only vaguely reme...In preparation for the upgrade, we will be performing board maintenance, such as moving boards to Lost Civilizations where appropriate. Lost Civilizations is a category for companies that have either been dissolved or acquired. The boards serve as both an archive of the old company posts, as well as a place for former employees to …3 days ago · Investors & Media. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Ardelyx’s financial performance into perspective. Volume: Today's Open: Previous Close: Data Provided by Refinitiv.Complete Ardelyx Inc. stock information by Barron's. View real-time ARDX stock price and news, along with industry-best analysis.2007. 267. Mike Raab. www.ardelyx.com. Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company’s lead product candidate is tenapanor for the treatment of patients with …Oct 9, 2023 · According to Seeking Alpha data, Ardelyx's market cap of $864.92M shows decent market confidence, especially with its robust revenue growth forecasts: 2023 at $100.6M, and 2024 at $175.84M ...May 17, 2024 · A high-level overview of Ardelyx, Inc. (ARDX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Under the terms of the agreement, Ardelyx will receive an upfront payment of $12 million and is eligible to receive additional milestones of up to $113 million, as well as tiered royalty payments on net sales ranging from the mid-teens to 20 percent.Fosun Pharma will have the exclusive rights to market and sell tenapanor in China. "As one of …Ardelyx (NASDAQ:ARDX): A Commercial-Stage Biopharma Stock with Growth Potential. 9d ago. ARDX. Press Releases. Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference. 1d ago. ARDX. The Fly. Ardelyx presents additional data at 2024 DDW conference on IBSRELA.Track Seres Therapeutics Inc (MCRB) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack ABVC BioPharma Inc (ABVC) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAfter the upgrade, the consensus from Ardelyx's seven analysts is for revenues of US$8.1m in 2022, which would reflect a concerning 26% decline in sales compared to the last year of performance ...Stuff They Don't Want You to Know looks at human species — and other ancient species we may and may not be related to. Advertisement Ask someone to describe what "ancient man" look...Revenue Per Employee. $595,917.60. Enterprise Value/EBITDA. -27.47. Home. Symbol. ARDX. Fundamentals. Get all financial information for Ardelyx Inc (ARDX) including Market Capitalization, PE Ratio, EBITDA, EPS, previous close and open price, 52 week high & 52 week low, Beta and much more.From discovery through commercialization, all of us at Ardelyx ® are driven to advance patient care with targeted, first-in-class, novel mechanism therapies that address significant unmet medical needs. We developed a unique and innovative platform that enabled the discovery of new biological mechanisms and pathways to create targeted, first ...If you're looking to learn more about your customers, then read about how a customer behavior analysis can help your business in this post. Trusted by business builders worldwide, ...ARDX, Ardelyx - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlinesArdelyx News: This is the News-site for the company Ardelyx on Markets Insider Indices Commodities Currencies StocksConference call scheduled for 4:30 p.m. Eastern Time. WALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced it will hold …May 17, 2024 · A high-level overview of Ardelyx, Inc. (ARDX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.30.61%. BEAT. Home. Symbol. ARDX. Checkout Ardelyx Inc (ARDX) earnings results, EPS expectations and actual EPS values for both quarterly and annual periods. Discover whether ARDX beat the street expectations or not?September 8, 2023 - 8:00 am. WALTHAM, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that Mike Raab, president and chief …After the upgrade, the consensus from Ardelyx's seven analysts is for revenues of US$8.1m in 2022, which would reflect a concerning 26% decline in sales compared to the last year of performance ..."The responder analysis from the PHREEDOM trial, the onset of action analysis from the Phase 3 program, and new data generated from our Phase 4 studies further build on the body of evidence that support the potential role that XPHOZAH, as a first-in-class phosphate absorption inhibitor, could play in the management of …FREMONT, Calif. and WALTHAM, Mass., July 29, 2021 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the discovery, development, and commercialization of innovative first-in-class medicines to improve treatment for people with kidney and cardiorenal diseases, today announced that it has …Aug 2, 2023 · Ardelyx, a publicly traded company on the NASDAQ under the ticker symbol ARDX, has just released its financial results for the second quarter of 2022. Best stocks to buy now ContactArdelyx is a well-funded biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. This presentation is intended for investor purposes only and is not intended for promotional purposes.Call it the Battle of the Waterslides. Call it the Battle of the Waterslides. In the last few years, the big boys of the cruise industry -- Royal Caribbean, MSC Cruises, Norwegian ...Q1 net loss was $26.8 million, but Ardelyx raised $51.9 million through sales of their common stock at an average price of about $3.35, leaving $130.4 million in total cash and investments as of ...Discover Ardelyx Inc (ARDX) market and community sentiment, movement in message volume, participation score and buzz level in the Stocktwits communityBy year 2025 revs could be ramping up between $300K - $0.5B. But an offering in this case is not a bad thing to support on going R&D. The more cash they are sitting only makes the company stronger in this case. Any lowball offer will be instantly rejected. BP loves lowballing companies on the verge of going belly up.3 days ago · Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update. Company reports $45.6 million in Q1 product-related revenue, including $28.4 million in net product sales revenue for IBSRELA and $15.2 million in net product sales revenue for XPHOZAH. 19 days ago - GlobeNewsWire.Investors & Media. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Ardelyx’s financial performance into perspective. Volume: Today's Open: Previous Close: Data Provided by Refinitiv.To access the live webcast of Ardelyx's session, please visit the Events & Presentations page within the Investor section of the Ardelyx website at ir.ardelyx.com. A replay of the webcast will be ...What is Ardelyx's Market Cap? ( NASDAQ: ARDX) Ardelyx 's market cap is $1.81B, as of May 22, 2024. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Ardelyx 's market cap is calculated by multiplying ARDX 's current stock price of $7.72 by ARDX 's total outstanding shares of …Find the latest Ardelyx, Inc. (ARDX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Greater Boston 400 Fifth Avenue, Suite 210 Waltham, MA 02451 Bay Area 34175 Ardenwood Boulevard Fremont, CA 94555Ardelyx (ARDX) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through ...Your lens into the world of crypto. See all Stocktwits emails. The latest messages and market ideas from James Johnston (@Johnstonj27) on Stocktwits. 50 years old, live out in Wildomar California, Grew up in Laguna Niguel and lived in Huntington Beach. Swing Trader and a test rider for Kawasaki Motors Corp.With warehouses located both in Canada and the US, customers can expect to receive their panels promptly. Expert Advice On Improving Your Home Videos Latest View All Guides Latest ...In the last reported quarter, Ardelyx’s product revenues from the sale of Ardelyx amounted to $4.9 million, signifying a sequential growth in revenues of 206.25%. We expect the product to have ...All debt owed by the company, including both long-term and short-term debt. This does not include accounts payable and similar liabilities, but may include leases depending on the analysis. $34 ...Conference call scheduled for 4:30 p.m. Eastern Time. WALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced it will hold …Congress kidney patient bill. “Ardelyx (NASDAQ:ARDX) traded higher on Tuesday after a kidney patient bill, dubbed HR-5074, moved into the markup phase in Congress, which, according to Jefferies, removed a key overhang for …TipRanks | Stock Market Research, News and Analyst Forecasts ...Track Intelligent Bio Solutions Inc (INBS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsArdelyx (ARDX) delivered earnings and revenue surprises of 33.33% and 40.61%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?Ardelyx (NASDAQ: ARDX) stock is taking off on Thursday after an advisory committee to the U.S. Food and Drug Administration (FDA) voted in favor of its kidney disease drug. This saw the FDA’s ...ARDX Strong upgrade from a top financial firm ARDX Ardelyx is a biopharmaceutical company that discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the US and internationally. On 3/2/2022 Jefferies Financial Group Upgraded ARDX from Hold to Buy raising the price target from $1.00 to $.May 17, 2023 · User Fee Goal Date: October 17, 2023. WALTHAM, Mass., May 17, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that the U.S. Food and Drug Administration (FDA) has accepted its resubmission of a New Drug ...Track reAlpha Tech Corp. (AIRE) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsIt offers a platform that enables the discovery of new biological mechanisms and pathways to create oral and small molecule therapies. Ardelyx was formerly known as Nteryx. The company was founded in 2007 and is based in Fremont, California. Headquarters Location. 34175 Ardenwood Boulevard. Fremont, California, 94555, United States. 510-745-1700.Apr. 05. MT. Ardelyx, Inc. Announces the Appointment of Mike Kelliher as Executive Vice President, Corporate Development and Strategy. Mar. 25. CI. Ardelyx Insider Sold Shares Worth $664,978, According to a Recent SEC Filing. Mar. 22. MT. Ardelyx, Inc. announced that it has received $50 million in funding.Ardelyx stock has received a consensus rating of buy. The average rating score is and is based on 19 buy ratings, 3 hold ratings, and 0 sell ratings. What was the 52-week low for Ardelyx stock?ARDX | Complete Ardelyx Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Discover real-time Ardelyx, Inc. Common Stock (ARDX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.Greater Boston 400 Fifth Avenue, Suite 210 Waltham, MA 02451 Bay Area 34175 Ardenwood Boulevard Fremont, CA 94555Ardelyx Inc. shares soared more than 60% in after-hours trading Wednesday, after the company reported positive results for a study of a proposed drug. Ardelyx said a second Phase 3 study of ...Track Crexendo Inc (CXDO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack BioCardia Inc. (BCDA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsArdelyx has a Phase 2 potassium lowering compound, RDX013, for the potential treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease and an early-stage program in metabolic acidosis, a serious electrolyte disorder in patients with CKD.ARDX. Net Product Sales Revenue: IBSRELA generated $80.1 million in 2023, with Q4 showing a 26% increase over Q3. 2024 Revenue Forecast: Ardelyx projects IBSRELA sales to reach between $140.0 to ...Currency in USD. Add to watchlist. 8.48 -0.83 (-8.92%) At close: 04:00PM EDT. 8.49 +0.01 (+0.12%) Pre-market: 04:02AM EDT. 1d. 5d. 1m. 6m. YTD. 1y. 5y. Max. Full screen.9 equities research analysts have issued 1-year price targets for Ardelyx's stock. Their ARDX share price targets range from $8.50 to $15.00. On average, they predict the company's stock price to reach $12.81 in the next year. This suggests a possible upside of 68.4% from the stock's current price.The painting appreciated nearly $150 million in less than 20 years. Pablo Picasso’s 1955 painting Les femmes d’Alger (Version ‘O’) fetched $179.4 million in a Christie’s auction on...All debt owed by the company, including both long-term and short-term debt. This does not include accounts payable and similar liabilities, but may include leases depending on the analysis. $34 ...Ardelyx Inc is a biopharmaceutical company that develops treatments for kidney and gastrointestinal diseases. Find out the latest stock price, quote and news for ARDX on CNBC, the trusted source ...At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.View the latest Ardelyx Inc. (ARDX) stock price, news, historical charts, analyst ratings and financial information from WSJ.Ardelyx released a business update Monday stating that the company expects its FDA-approved IBS treatment, Ibsrela, to achieve greater than ten percent market share at peak and generate more than ...Ardelyx Inc. ARDX:US. Nasdaq GM (USD) · Market closed. 7.72. –0.21 –2.65% As of 12:00 AM EDT 05/21/24. Prev. close. 7.93 USD. 7.72 USD. 3:58 PM. 9:30a …ARDX, Ardelyx - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlinesAug 2, 2023 · Ardelyx, a publicly traded company on the NASDAQ under the ticker symbol ARDX, has just released its financial results for the second quarter of 2022. Best stocks to buy now ContactCurrency in USD. Add to watchlist. 8.48 -0.83 (-8.92%) At close: 04:00PM EDT. 8.49 +0.01 (+0.12%) Pre-market: 04:02AM EDT. 1d. 5d. 1m. 6m. YTD. 1y. 5y. Max. Full screen.. View the latest Ardelyx Inc. (ARDX) stock The latest messages and market ideas from Dubai Tradi Ardelyx had a negative return on equity of 41.65% and a negative net margin of 41.36%. The firm’s revenue for the quarter was up 303.5% on a year-over-year basis. During the same quarter in the ... Upon approval, XPHOZAH would be the first and only phosphate absorption inhibitor for adult patients with CKD on dialysis with hyperphosphatemia. The company will host a conference call on December 29, 2022, at 8:00 AM ET. To participate in the conference call, please call (866) 374-5140 (toll-free) or (404) 400-0571 (toll) and …To access the live webcast of Ardelyx's session, please visit the Events & Presentations page within the Investor section of the Ardelyx website at ir.ardelyx.com. A replay of the webcast will be ... Mar 2, 2023 · Ardelyx (ARDX) delivered earnings and revenue...
Continue Reading